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Recent studies have suggested that defective medullary trapping of
ammonia underlies the acidosis associated with renal failure and sets in
motion maladaptive compensatory mechanisms that contribute to the
progression of renal disease. Since a renal concentrating defect is an
early functional abnormality in autosomal dominant polycystic kidney
disease (ADPKD), defective medullary trapping and urinary excretion
of ammonia may also occur early and have important pathophysiolog-
ical consequences. The urinary pH and excretions of ammonia, titrat-
able acid, and bicarbonate, were measured during a 24-hour baseline
period and following the administration of ammonium chloride (100
mg/kg body wt) in ADPKD patients with normal glomerular filtration
rate and in age- and gender-matched healthy control subjects. The distal
nephron hydrogen ion secretory capacity was assessed during a bicar-
bonate infusion. Ammonia, sodium, pH, C3dg, and C5b-9 were mea-
sured in cyst fluid samples. The excretion rates of ammonia during the
24-hour baseline period and following the administration of ammonium
chloride were significantly lower, and the relationship of ammonia
excretion to urinary pH was significantly shifted downward in ADPKD.
No difference in the increment of urinary pCO2 (A pCO2) or the
peripheral blood-urine pCO2 gradient (U-B pCO2) between ADPKD
patients and control subjects was detected during a sodium bicarbonate
infusion. Calculated concentrations of free-base ammonia in cyst fluid
samples exceeded those calculated from reported concentrations of
ammonia in renal venous blood of normal subjects. C3dg and C5b-9
were detected in some cyst fluids. The urinary excretion of ammonia is
reduced in ADPKD patients with normal glomerular filtration rate. This
reduction is not explained by a lower production of ammonia in the
renal cortex or by a defect of proton secretion in the collecting ducts. It
is likely due to an impaired renal concentrating mechanism and reduced
trapping of ammonia in the renal medulla. It may contribute to the
pathogenesis of nephrolithiasis and, more importantly, to the progres-
sion of the interstitial inflammation and cystic changes seen in ADPKD.
The urinary excretion of ammonia (free-base ammonia or
NH3 and ammonium ion or NH4) plays a central role in the
maintenance of acid-base balance, since the bicarbonate neces-
sary to neutralize the daily hydrogen ion load results from the
production of ammonia by the proximal tubules and excretion
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into the urine [1—3]. The excretion of ammonia into the final
urine is a complex process that requires active reabsorption in
the thick ascending loop of Henle, countercurrent concentra-
tion in the renal medulla and diffusion trapping by protonation
in the collecting duct lumen. A low urinary excretion of
ammonia underlies the inappropriately low urine pH and uric
acid nephrolithiasis associated with gout [4—6] and the acidosis
of renal failure [7—9]. The marked reduction in the urinary
excretion of ammonia seen in uremia is due to defective
trapping of ammonia in the renal medulla despite an enhanced
ammoniagenesis and an increased concentration of ammonia in
the renal cortex [10]. It has been suggested that this compen-
satory enhancement of ammonia production in the cortical
tissue contributes to the progression of renal injury in renal
insufficiency [11, 12].
Individuals with autosomal dominant polycystic kidney dis-
ease (ADPKD) develop a renal concentrating defect prior to
any reduction in glomerular filtration rate [13—16]. Gabow et al
found a close correlation between the severity of the concen-
trating defect and the structural abnormality. They suggested
that the disruption of the vascular tubular architecture of the
renal medulla is responsible for this early functional abnormal-
ity in ADPKD [16]. If the loss of a normal corticomedullary
concentration gradient in ADPKD also results in a defective
urinary excretion of ammonia, it could have serious pathophys-
iological consequences.
To determine whether patients with ADPKD can produce
and transfer ammonia to the urine normally, we studied the
urine pH and the urinary excretion of ammonia, titratable acid,
and bicarbonate in baseline conditions and following an acute
ammonium chloride challenge in ADPKD patients with normal
glomerular filtration rate and in age- and gender-matched
healthy control subjects. We also assessed their distal nephron
hydrogen ion secretory capacity during a bicarbonate infusion.
To estimate the renal concentration of ammonia in ADPKD we
analyzed cyst fluids from patients with ADPKD and different
levels of glomerular filtration rate. The results of these studies
provide support to the hypothesis that patients with ADPKD
cannot transfer ammonia normally to the urine and that this
defect contributes substantially to the pathophysiology of this
disease.
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Methods
Patients
Eight patients with ADPKD and normal serum creatinine,
and eight age- and gender-matched healthy control subjects
were studied in the Clinical Research Center for three days. The
diagnosis of ADPKD was based on a family history of this
disease and the demonstration of multiple bilateral renal cysts
by computerized tomography. The average renal volume mea-
sured by computerized tomography was 1151 cc/l.73 m2 BSA
(range 718 to 1702 cc/1.73 m2) [171. All subjects were on no
medications for at least two weeks and were eating their regular
unrestricted diet. On the days of the study the subjects con-
sumed a diet containing 30 kilocalories and 1 g of protein/kg
body weight, 130 mEq of sodium, and 80 mEq of potassium
daily. These studies were approved by our Institutional Review
Board, and the participating subjects signed an informed con-
sent form.
Baseline studies and ammonium chloride challenge
Every morning at 7 a.m. blood pressure was taken in the
sitting position. On the first day of the study blood was obtained
for determination of creatinine and electrolytes, and urine
collected under a thin layer of mineral oil in a glass container
kept in ice from 7a.m. to 3p.m., 3p.m. to 11 p.m., and 11 p.m.
to 7 a.m. for determinations of pH, ammonia, titratable acid,
bicarbonate, net acid excretion, creatinine, and urea. Meals
were given at 8 a.m., noon, and 6 p.m. The baseline protein
intake was estimated using the formula: protein intake (g/24 hr)
= 6.25 x (urea [g 24 hr]/2,14 + 0.031 x body wt [kg]) [18]. On
the second day of the study, the participants drank 200 cc of
water at 6 a.m. and remained fasting until noon. At 7 a.m.
venous blood was obtained into a hepannized tube for exami-
nation of acid base balance. Between 7 a.m. and 8 a.m. 100 mg
NH4CI/kg body wt in the form of a 10% ammonium chloride
syrup were administered p.o. and during the duration of the test
100 cc of water were administered every hour [19]. From 8 a.m
to 10 a.m. and from 10 a.m. to noon urine was collected under
a thin layer of mineral oil in glass containers kept in ice for
determinations of pH, ammonia, titratable acid, bicarbonate,
and net acid excretion. At the end of the second urine collection
venous blood was obtained for examination of acid base bal-
ance. Estimated protein intakes, creatinine clearances, and
excretion rates were expressed per 1.73 m2 of body surface
area.
Determinations of urine delta pCO2 ( pCO2) and urine-blood
pCO2 (U-B pCO2) gradients in alkaline urines
Seven ADPKD patients and seven control subjects returned
for a third day of the study after several weeks. At 7 a.m. urine
was collected under a thin layer of mineral oil for examination
of baseline urine pCO2, and venous blood was obtained for
examination of acid-base balance. An intravenous infusion of
5% sodium bicarbonate at 1.5 mllmin was started, and urine and
blood were collected every 30 minutes for examinations of pH,
bicarbonate, and pCO2. These measurements were performed
within five minutes after each collection. After each 30 minute
collection, the rate of bicarbonate infusion was increased by 1.5
mI/mm to a maximum rate of 6 ml/min if needed. The infusion
of bicarbonate was terminated when the urine pH reached 8.0.
Urine z pCO2 values were calculated by subtracting the base-
line urine pCO2 from the timed collection pCO2 [20]. Urine-
blood pCO2 gradients were calculated by subtracting the pe-
ripheral blood pCO2 from the timed collection pCO2 [21, 22].
Analysis of cyst fluids
Fifty-four cyst fluids were obtained from nine ADPKD pa-
tients. Four of these patients had a normal serum creatinine,
three had moderate renal insufficiency (serum creatinine con-
centrations between 2 and 5 mg/dl), one patient had end stage
renal failure (serum creatinine 12.4 mgldl), and one patient had
been on hemodialysis for two years. The samples were obtained
by percutaneous needle aspiration in one patient, at the time of
surgical cyst decompression for pain in five patients, and at the
time of bilateral nephrectomy for massive renal enlargement in
three patients. Cysts sampled were large (>3 cm in diameter),
superficial and totally or partially contained within the renal
cortex. Twenty samples from one patient were obtained under
a thin layer of mineral oil, in glass containers kept in ice and
processed immediately. In the remaining patients cyst fluids
were collected in plastic tubes kept in ice, frozen within three
hours at —20°C and analyzed within two months from the time
of the collection. Cyst fluid measurements included pH, bicar-
bonate, ammonia, sodium, potassium, and osmolality. The pH
values of cyst fluids not obtained under oil and kept frozen
before measurement were calculated from the bicarbonate
concentrations using the Henderson-Hasselbalch formula and
assuming an initial CO2 concentration of 1.2 mmol [23]. The
concentrations of ammonia in three cyst fluids kept frozen at
—20°C for three months (6.9, 25.6, and 96.0 jsmol/dl) were not
different from those measured immediately after collection
under mineral oil (5.7, 27.2, and 97.1 pmol/dl) using split sample
aliquots. The concentrations of a breakdown product of C3
(C3dg) and of the terminal complement complex (C5b-9) were
measured in some cyst fluids. Cyst fluids were classified as
"nongradient" when the sodium concentration was 120
mEq/liter and as "gradient" when it was 100 mEq/liter.
Analytical methods
Urine pH was measured with a Copenhagen Radiometer
pHmeter. Blood pH and pCO2 were measured using an Instru-
mentation Laboratories gas analyzer (Lexington, Massachu-
setts, USA). Urinary ammonia was measured by the Berthelot
method [24]. Urine titratable acidity was measured by titration
with 0.1 M NaOH up to a pH of 7.40. Urinary bicarbonate was
measured with a Natelson microgasometer [25]. Net acid ex-
cretion was calculated as: ammonia + titratable acid — bicar-
bonate. Cyst fluid ammonia was measured using Kodak Ek-
tachem Clinical Chemistry Slides (NH3/AMON) and a Kodak
Ektachem 700 Analyzer [26]. Concentrations of free-base am-
monia (NH3) were estimated from total ammonia concentra-
tions and pH values with a transformation of the Henderson-
Hasselbaich equation: [NH3] = total ammonia/i +
using an acidic dissociation constant of 9.02 [27]. Creatinine,
urea, osmolality, sodium, and potassium were measured by
techniques routinely used in our Renal Function Laboratory
[28]. Cyst fluid C3dg and C5b-9 were measured by ELISA [29].
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Table 1. Characteristics of the ADPKD patients and control subjects
ADPKD(N = 8)
Control
(N = 8)
P
value
Gender(M:F) 3:5 3:5 NS
Age years 33 8 32 7 NS
Body surface area m2 1.91 0.07 1.75 0.23 NS
Mean arterial pressure mm Hg
Estimated protein intake gII.73 in2
96 10
73 16
80 7
71 21
0.004
NS
Serum creatinine mg/d!' 0.99 0.14 0.94 0.13 NS
Creatinine clearance ml/min/1.73 in2 107 9 108 21 NS
Plasma sodium mEqlliter 141 2 140 2 NS
Plasma potassium mEqiliter 4.3 0.3 4.2 0.2 NS
Plasma chloride mEq/liter 104 3 105 2 NS
Plasma bicarbonate mEqiliter 26 2 25 2 NS
Data are mean SD.
a Conversion factor to SI units (moI/liter) = 88.4
Statistical methods
Two sample rank-sum and t-tests were used to compare the
ADPKD patients and the control subjects for the variables of
interest. Within individuals linear slopes were calculated to
reflect the relationship between various dependent variables
and urinary pH. The means of these slopes were then compared
in the two groups. In addition, multiple regression was em-
ployed to simultaneously assess the impact of pH, group
assignment, and their interaction on various dependent vari-
ables. Degree of association between pairs of numeric contin-
uous variables was assessed using linear and rank correlations.
All comparisons were two-sided in nature with P 0.05 taken
as evidence of differences not attributable to chance.
Results
The age, gender, body surface area, mean arterial pressure,
estimated protein intake, creatinine clearance, plasma creati-
nine and electrolytes of the ADPKD patients and control
subjects are summarized in Table 1. The mean arterial pressure
of the patients with ADPKD was significantly higher than that
of the controls although none of these patients had been
previously diagnosed or treated for hypertension. No other
significant differences were detected. Estimated protein intakes
and creatinine clearances were positively correlated (P = 0.02).
The urine flow rates and pH values and the urinary excretions
of ammonia, titratable acid, bicarbonate, and net acid for the
three eight-hour baseline periods and the two two-hour periods
following the administration of NH4C1 are shown in Figure 1.
The urinary excretion of ammonia was significantly lower in the
ADPKD patients during the sleep/fasting/antidiuretic period
(11 p.m. to 7 a.m.) of the first day of the study and during the
first two-hour period following the administration of NH4C1.
The average urinary excretion rate of ammonia during the
24-hour baseline period was lower at 14.5 3.9 Eq/minIl .73
m2 as compared to 19.9 5.4 pEq/min/1 .73 m in the controls
(P 0.039 by t-test, and 0.082 by rank-sum test). The average
urinary excretion rate of ammonia during the four hours follow-
ing the administration of NH4CI was also lower at 33.1 11.1
.tEq/min/1 .73 m2 in the ADPKD patients, as compared to 42.3
6.5 Eq/mi&1 .73 m in the controls (P =0.063 by t-test, and
0.028 by rank-sum test). The renal volumes measured by
computerized tomography were negatively correlated with the
urinary excretions of ammonia at baseline (r =
—0.33), follow-
ing the administration of NH4CI (r =
—0.52) and during the
sleep/fasting/antidiuretic period (r = —0.64, P 0.086), as well
as with the intercepts of the regression lines for urinary excre-
tion of ammonia over pH (r =
—0.60). Excluding an ADPKD
patient who was unable to lower the urine pH to 5.3, these
correlation coefficients were —0.36, —0.57, —0.82 (P = 0.017)
and —0.57.
No significant differences in the rates of titratable acid,
bicarbonate, and net acid excretions were detected between
patients and controls in the first day of the study. The urine pH
was significantly lower in the ADPKD patients during the 3 to
11 p.m. period. No significant differences in urine pH were
detected in the 7 a.m. to 3 p.m. and 11 p.m. to 7 a.m. periods,
nor was there a significant difference in urine pH, titratable
acid, and bicarbonate after the administration of NH4C1. One of
the eight ADPKD patients was unable to lower the urine pH to
5.3; this patient had the highest ammonia excretion at urine pH
values between 6 and 7 in the ADPKD group. The urine flow
rate and net acid excretion in the first two hours following the
administration of NH4C1 were significantly higher in the control
subjects than in the ADPKD patients. No significant differences
between ADPKD patients and controls were detected in the
average urinary excretion rates of titratable acid, bicarbonate
and net acid during the 24-hour baseline period and during the
four hours following the administration of ammonium chloride.
The relationship of the urinary ammonia excretion to urinary
pH in the ADPKD patients and control subjects is shown in
Figure 2. No significant difference in the slopes of the regres-
sion lines was detected using analysis of individual slopes or
multiple regression analysis. The analysis of covariance showed
an 8.1 1.9 (suM) pEq/min/l .73 m2 downward shift in the
regression line for ADPKD patients as compared to controls
(P value = 0.001).
During the bicarbonate infusion the urine E pCO2 values were
positively correlated with the urine bicarbonate concentrations
(P = 0.014) and negatively correlated with the urine flow rate
(P < 0.001). These correlations were independent of each other,
and there was no significant interaction between them (Fig. 3).
Similar correlations were observed for U-B pCO2. No signifi-
cant differences were detected between the ADPKD patients
and the control subjects. The maximal urine pCO2 and U-B
pCO2 values were similar in both groups (Table 2). Although
not statistically significant, the baseline urine pCO2 tended to be
lower in the ADPKD patients (35 4 torr) than in the control
subjects (41 9 torr).
The concentration of ammonia in the cyst fluids ranged from
2.3 to 3,235 tmol/d1. These concentrations were negatively
correlated with the cyst fluid pH (Fig. 4) and sodium (r =
—0.64,
P < 0.001). The ammonia concentration in "nongradient cyst"
fluids (with a sodium concentration  120 mEq/liter and a pH of
7.2 to 7.4) was 14.3 12.0 (range 3.1 to 51.1 mol/dl). The
estimated mean concentrations of free-base ammonia in the
cyst fluids of nine patients with various glomerular filtration
rates ranged between 0.08 and 0.42 mol/dl. The lowest con-
centrations of free-base ammonia were estimated in one patient
with negligible renal function who had been on dialysis for two
years. No significant correlation between the concentrations of
free-base ammonia and renal function was detected in the
remaining eight patients with serum creatinines ranging be-
tween 0.8 and 12.4 mg/dl. No significant difference in the
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Fig. 2. Urinary excretion rate of ammonia
plotted against urine pH in eight ADPKD
patients (0) and eight age- and gender-
matched control subjects (•) during three 8-
hour periods prior to and two 2-hour periods
following the administration of ammonium
chloride. No significant difference in the
slopes of the regression lines was detectted
using multiple regression analysis. The
analysis of covariance assuming a common
slope as displayed in the figure showed an 8.1
ixEq/minIl .73 m2 downward shift in the
regression line for the ADPKD patients as
pH compared to control subjects (P < 0.001).
concentration of free-base ammonia was detected between
gradient (0.19 0.21 moUdl) and non-gradient (0.29 0.22
mol/dl) cyst fluids.
The markers of complement activation C3dg and C5b-9 were
measured in renal cyst fluids from three patients. Nineteen of 20
and 13 of 20 cyst fluids from one patient with a serum creatinine
of 12.4 mg/dl had detectable levels of C3dg (65 35, range 0 to
124 U/mI) and C5b-9 (4.7 5.2, range 0 to 19.7 U/ml),
respectively. One of three cyst fluids in a patient with a serum
creatinine of 3.8 mgldl had detectable levels of C3dg. None of
five cyst fluids in the remaining patient with a serum creatinine
of 1.0 mg/dl had detectable levels of C3dg or C5b-9. The
concentrations of C3dg and C5b-9 were not correlated with pH
or concentrations of sodium or ammonia in the cyst fluids.
Discussion
Despite marked enlargement of the kidneys and distortion of
the renal anatomy the glomerular filtration rate in ADPKD
remains normal until a very late stage of this disease. Early
renal functional abnormalities include the loss of urinary con-
centrating capacity [13—16] and abnormalities in the renal han-
dling of sodium that result in the development of hypertension
[30—33]. An impairment of urinary acidification [15, 34—36] and
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Fig. 3. Correlation between urine flow rate,
pCO2 increment (i pCO2) and bicarbonate
concentration in multiple (2 to 6) urine
samples from seven ADPKD patients (open
symbols) and seven age- and gender-matched
control subjects (closed symbols) during a
sodium bicarbonate infusion. The bicarbonate
infusion was terminated when the urine pH
reached 8.0. Significant and independent
correlations were observed between pCO
and bicarbonate concentration (P = 0.014)
and between pCO2 and urine flow rate (P <
0.001). No difference was detected between
ADPKD patients and control subjects.
TabJe 2. Maximal urine i pCO2 and U-B pCO2 during sodium bicarbonate infusion in ADPKD patients and control subjects
Plasma
HCO3
mEqiliter
Urine
pH
HCO3
mEqiliter
pCO2
torr
Flow
mI/mm
Maximal
U-B
pCO2
torr
Maximali pCO2
torr
ADPKD
1
2
3
4
5
6
7
Mean±sD
Controls
1
2
3
4
5
6
7
Mean SD
34
31
28
30
35
36
31
35
36
34
27
34
28
37
8.1
8.1
6 5
6.9a
8.0
8.0
6.8a
8.0
8.0
79
7.2a
8.275
8.0
169
127
a
12
110
124
l0
115
143
iosa
24
168
7?
148
64
52
79
73
51
65
68
57
59
59
64
63
126
68
3.9
2.2
0.8
1.8
5.5
4.8
0.5
3.3
8.0
6.3
0.3
2.8
0.8
6.2
19
7
30
22
10
10
14
16±8
5
13
7
18
14
8?
18
23 28
28
23
43
42
21
25
28
30±9
14
19
9
38
27
88
18
30 27
a Largest U-B pCO2 and pCO2 detected despite continuing bicarbonate infusion to achieve a urine pH 8.0 and urine bicarbonate> 100
mEq/liter
excretion of ammonia [151 have also been reported to occur
early in the course of ADPKD.
A defect in urinary acidification as an early manifestation of
ADPKD was first noted by Preuss et al [15], but it has not been
convincingly demonstrated. This investigator observed that two
of four ADPKD patients with creatinine clearances over 73
mi/mm were unable to lower their urine pH to 5.3 or below after
an acute NH4CI challenge as compared to 1 of 12 unaffected
family members. Milutinovic et al reported that three of six
ADPKD patients with inulin clearances exceeding 86 mllmin
were unable to lower the urine pH to 5.3 or below as compared
to three of ten family members without ADPKD [34]. Garcia
DIaz et a! made a diagnosis of distal renal tubular acidosis
(RTA) in an ADPKD patient with a creatinine clearance of
34 mi/mm, plasma bicarbonate of 14 mEq/liter, and a urine pH
of 5.9 [35]. More recently Pabico and McKenna found a
defective urinary acidification after an NH4C1 load in three of
four ADPKD patients with an average inulin clearance of 116
mI/mm [36]. Contrary to these observations, the urine acidifi-
cation capacity of seven ADPKD patients in two additional
studies was found to be normal [37, 38]. In the present study we
did not detect any significant difference in the urine pH between
ADPKD patients and age- and gender-matched controls follow-
ing an acute NH4C1 challenge, although one of the ADPKD
0
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Fig. 4. Correlation between pH and ammonia concentration in 54 cyst
fluids obtained from 9 patients with ADPKD.
patients was unable to lower the urine pH to 5.3 or below.
These results suggest that the majority of ADPKD patients with
normal glomerular filtration rate can acidify their urine nor-
mally.
To determine whether patients with ADPKD have a defect in
proton secretion in the collecting ducts, we measured the
i pCO2 and U-B pCO2 during a sodium bicarbonate infusion
[20—22]. z pCO2 and U-B pCO2 were positively correlated with
the urine bicarbonate concentration and negatively correlated
with urine flow. In the presence of bicarbonaturia the CO2
released by nonenzymatic dehydration of carbonic acid in the
collecting ducts is trapped in the renal medulla by the counter-
current system [39]. Under conditions of brisk diuresis, how-
ever, the medullary trapping of CO2 and, as a result, the urine
i pCO2 and U-B pCO2 are blunted. Under these conditions no
significant difference between the ADPKD patients and the
control subjects was observed, which suggests that there is no
significant defect of proton secretion in the collecting ducts in
the majority of patients with ADPKD and normal glomerular
filtration rate.
Preuss et al also reported that the urinary ammonia excretion
factored by glomerular filtration rate during a four-day NH4C1
challenge was lower in seven ADPKD patients with glomerular
filtration rates between 44 and 93 ml/min than in six normal
control subjects [15]. They argued that, as urine volume plays
only a minor role in regulating ammonia excretion and as their
patients did decrease the urine pH below 6.5, the major
reduction in excretion of ammonia observed in their study had
to be secondary to decreased production. This interpretation
was based on a simple view of renal transport of ammonia,
according to which free-base ammonia produced in the proxi-
mal tubules diffuses homogeneously to all renal compartments,
and is protonated and trapped as ammonium ion in the collect-
ing ducts.
Neither our study nor previous studies measured the renal
production of ammonia. Nevertheless, our determinations of
ammonia concentration in cyst fluids provide circumstantial
evidence against a decreased renal production to explain the
low urinary excretion of ammonia in ADPKD. Renal cysts of
the size sampled in our study are disconnected from the
nephrons from which they originate [40] and have a rapid fluid
turnover [41] The epithelial cysts lining the nongradient cysts
cannot maintain a concentration gradient between the sur-
rounding interstitium and the fluid inside the cyst [42, 43].
Therefore, the electrolyte composition of "nongradient cyst"
fluids is likely to reflect that of the surrounding interstitial fluid.
The concentrations of ammonia in our "nongradient cyst"
fluids with pH 7.2 to 7.4 (14.3 12.0 moUdl) were higher than
those measured in renal venous blood in normal subjects (6.3
0.4 to 7.8 2.2 tmolIdl) [44, 45]. Although "gradient cyst"
fluids had higher concentrations of ammonia than "non-gradi-
ent cyst" fluids (explained by their lower pH and trapping of
ammonia by non-ionic diffusion and protonation), no significant
difference in the concentrations of free-base ammonia was
detected. This suggests that free-base ammonia freely perme-
ates both types of cysts and that, as sampled cysts were
partially or totally contained within the renal cortex, its con-
centration in the cyst fluids likely reflects that in the cortical
tissue. It has been demonstrated that the concentration of free-
base ammonia in the renal venous plasma approximates that in
the renal cortex [46]. In our cyst fluids the estimated concen-
trations of free base ammonia (0.08 to 0.42 jimolldl) also
exceeded those estimated in normal renal venous plasma (0.13
0.01 to 0.16 0.04 molJdl) [44, 45].
Significant advances in the understanding of the renal trans-
port of ammonia have occurred in the last decade [1—3]. The
urinary excretion of ammonia far exceeds that predicted by a
simple diffusion trapping model [47] and is contingent on the
accumulation of ammonia in the medullary tissue [48]. This
accumulation of ammonia in the medullary tissue depends on a
number of processes which include apical versus basolateral
secretion of ammonia by the proximal tubules, active transport
by the Na/K/2Cl cotransporter in the thick ascending loop
of Henle, and normally functioning countercurrent multiplica-
tion and exchange mechanisms. An altered polarity of the
secretion of ammonia in the proximal tubules in ADPKD cannot
be ruled out, as the intrarenal renin-angiotensin system is
activated in ADPKD [30—33], and angiotensin II has been
shown to preferentially stimulate the basolateral secretion of
ammonia [49, 50]. The transport of ammonia in the thick
ascending loop of Henle might also be abnormal in ADPKD
since studies of cyst-derived epithelial cells cultured on perme-
able membranes have suggested a reverse polarity of Na/K/2
Cl cotransporters [51]. More compelling evidence indicates
that the countercurrent multiplication and exchange mecha-
nisms are disturbed early in ADPKD. Several studies have
demonstrated that a loss of urinary concentrating capacity is
one of the earliest manifestations of this disease [13—16]. The
architecture of the renal medulla with a close juxtaposition of
ascending and descending vasa recta in the inner stripe as well
as between the ascending vasa recta and the straight proximal
tubules in the outer stripe is essential to maintain a normal
concentration gradient [52] and may be altered early in the
development of ADPKD. Gabow et al have demonstrated a
significant correlation between the reduction in renal concen-
trating capacity and the severity of the structural disorganiza-
tion of the polycystic kidneys [16]. Thus, the loss of the
corticomedullary concentration gradient due to an alteration of
the countercurrent multiplication and exchange mechanisms
caused by the structural changes associated with ADPKD is a
likely explanation for the abnormal urinary excretion of ammo-
nia in this disease. Consistent with this interpretation is the fact
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that the difference in urinary excretion of ammonia between
ADPKD patients and control subjects in our study was most
clearly demonstrated during the sleep/fasting/antidiuretic pe-
riod, during which the urinary concentrating mechanisms are
more likely to play a role. The significant negative correlation
observed during this period between ammonia excretion and
renal volume, presumably a reflection of the structural abnor-
mality, also supports this interpretation.
Defects in the urinary excretion of ammonia have also been
observed in other renal disorders associated with alterations in
medullary structure and/or loss of urinary concentrating capac-
ity such as gout [4—6], sickle cell anemia following the admin-
istration of indomethacin [53], and old age [54, 55]. A similar
defect may exist in type I or distal RTA, where it has been
recently proposed that the transition from incomplete distal
RTA, with normal urinary excretion of ammonia, to overt distal
RTA, with reduced ammonia excretion, is due to medullary
damage resulting from interstitial inflammation and nephrocal-
cinosis [561.
Abnormalities in the renal transport of ammonia in ADPKD
may have substantial consequences. They may explain, for
example, the low urinary pH and citrate excretion and the
frequency of uric acid calculi reported in some patients with this
disease [38]. More importantly, observations in subtotally ne-
phrectomized rats [10, 11], an experimental model with prom-
inent interstitial inflammatory cell infiltrates and tubular dilation
[57], suggest that a defect in the renal transport of ammonia may
contribute to the progression of the cystic and interstitial renal
disease. The low urinary excretion of ammonia in this experi-
mental model is caused by defective trapping in the renal
medulla, while the production and concentration of ammonia in
the renal cortex are actually increased [10]. A high concentra-
tion of ammonia is not innocuous. Free-base ammonia can
disrupt a reactive internal thiolester bond within the alpha
subunit of the third component of complement (C3) and result in
complement activation and interstitial inflammation [11, 58].
The frequent observation of interstitial inflammatory infiltrates
between and around the cysts [59, 60], the presence of cyto-
kines in cyst fluids [61], and our preliminary observations that
at least some cyst fluids contain markers of complement acti-
vation suggest that a similar mechanism could be operating in
ADPKD. Renal parenchymal calcifications, which are fre-
quently observed in both ADPKD [62] and end-stage renal
failure [63] may be the end result of the interstitial inflamma-
tion.
It is also possible that the renal production of ammonia per se
has an effect on cyst formation. This hypothesis was proposed
[64] following the observation of an association between
chronic hypokalemia and renal cyst development [65]. It has
been known for some time that the chronic administration of
ammonium chloride to rats causes renal hypertrophy [66, 67]
and that renal hypertrophy develops in a number of conditions
(chronic hypokalemia, metabolic acidosis, protein loading) [68]
which have in common an enhanced renal ammoniagenesis. In
rabbit proximal tubular cells ammonia results in an increase in
RNA and protein content, stimulation of protein synthesis, and
inhibition of protein degradation, without change in DNA
synthesis [69]. How these changes could lead to cyst formation
is not clear, but the hypothesis linking renal ammoniagenesis
and cystogenesis has received additional support from obser-
vations indicating that the administration of ammonium chlo-
ride markedly enhances [70, 71] and the administration of
potassium or sodium bicarbonate markedly suppresses [71] the
development of autosomal dominant renal cystic disease in
Han:SPRD rats.
The normal renal medulla in the antidiuretic state contains
concentrations of free-base ammonia which exceed 100-fold
those in the renal cortex [72]. The hyperosmolar concentrations
of sodium chloride and urea in the medullary interstitium in this
state prevent the inflammatory response that would result from
ammonia-induced activation of the alternate complement path-
way [73]. When the renal concentrating capacity is impaired
and the production of ammonia is enhanced, as for example in
chronic hypokalemia [45] or distal RTA [56], the medullary
environment becomes more propitious for the development of
interstitial inflammation. In these conditions interstitial inflam-
mation [74, 75], nephrocalcinosis [75—78], and cyst formation
[68, 78—80] may occur in the renal medulla. Since ADPKD
patients may have an impaired renal concentrating capacity
with inappropriately high tissue concentrations of ammonia,
medullary interstitial disease similar to that observed in patients
with chronic hypokalemia and distal RTA may ensue and
explain the distal acidification defect reported in some patients
with this disease [15, 34—36].
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